Search Results - "Kacska, S"
-
1
-
2
Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial
Published in Journal of Crohn's and colitis (01-09-2014)“…Oral budesonide 9mg/day represents first-line treatment of mild-to-moderately active ileocolonic Crohn's disease. However, there is no precise recommendation…”
Get full text
Journal Article